勃林格殷格翰的能倍乐使用说明

In clinical trials, patients experienced statistically significant improvements in lung function (FEV1) and had a similar safety profile to tiotropium or olodaterol. Respimat is a classic drug for the stable treatment of chronic obstructive pulmonary disease (COPD). Its effect lasts for 24 hours, so it only needs to be used once a day. Let’s learn about Boehringer Ingelheim’s Instructions for Use of Respimat.

Respimat is effective 24 hours a day, so it only needs to be used once a day, and if possible, at the same time every day. Spray twice with each use. Since COPD is a long-term disease, use Respimat every day, not just when you have breathing problems. Do not exceed recommended dosage.

When using Respimat, pull up to open the dust cap and open the nozzle. Remove one capsule from the packaging (remove only immediately before use) and place it in the central chamber. Firmly close the nozzle until you hear a click, leaving the dust cap open.

Holding the powder inhaler with the mouthpiece upward, press the green piercing button fully once, then release. This punctures many small holes in the capsule, allowing the medicine to be released when you inhale. Hold the powder inhaler tightly with your lips, keep your head upright, and inhale slowly and deeply. You can hear the capsule vibrating at this point.

When you inhale to the maximum, hold your breath for 10 seconds and take out the powder inhaler from your mouth. After that, exhale slowly. Open the spout again, pour out the used capsule and discard it. Close the mouthpiece and dust cap and store the inhaler.

Boehringer Ingelheim is a pharmaceutical company dedicated to human biopharmaceutical chemistry and animal health products. It is also the world's largest privately held pharmaceutical company. Boehringer Ingelheim's main research areas include: immune and respiratory diseases, cardiovascular and metabolic diseases, central nervous system diseases, and tumors. Boehringer Ingelheim has a complete biopharmaceutical industry chain, from genetic engineering of cells to manufacturing, and commercial production of off-the-shelf medicines for external industrial customers.

It has outstanding localization selectivity for bronchial dilation. Respimat has similar affinity for five choline receptors (M1-M5). It dilates bronchial smooth muscle by binding to M3 receptors on smooth muscle. This effect is competitive and reversible.